I do agree with you that it is strange that the current value of BMOD is so low compare to other biotech. However, I still have some issues with the "timing" of some PR. Why someone would state that accuracy might be as high as 100%and then come to a final phase II showing "only" 81%. I only wish that they will republish their phase II result with the revised reading system to show how accurate it might be using data gathered during that phase II.